Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_assertion type Assertion NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_head.
- NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_assertion description "[The administration of TACE therapy may increase the risk of HBV reactivation in HBsAg-negative/anti-HBc-positive patients diagnosed with unresectable HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_provenance.
- NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_assertion evidence source_evidence_literature NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_provenance.
- NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_assertion SIO_000772 22897940 NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_provenance.
- NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_assertion wasDerivedFrom befree-20140225 NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_provenance.
- NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_assertion wasGeneratedBy ECO_0000203 NP212137.RAXESu9sMh4A0eRofEeC0U-TEJKz1BUVAsoREHj7MVBOA130_provenance.